eHealth vs Ethos Technologies
EHTH and LIFE side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EHTH and LIFE compare
Ethos Technologies is the larger company, worth 177 times as much as eHealth ($2.2B against $12.3M).
Ethos Technologies grew revenue faster over the last twelve months (52.0% versus −13.6% for eHealth).
Ethos Technologies keeps more of each dollar of sales as profit, with a net margin of 18.4% compared with 4.9% at eHealth.
Ethos Technologies scores higher on the StockData Score (10 against 8 for eHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EHTH | LIFE |
|---|---|---|
| Size and price | ||
| Market cap | $12.3M | $2.2B |
| Share price | $0.383 | $33.99 |
| Change, 1 year | −90.4% | 1689% |
| Change, 5 years | −98.3% | – |
| Beta (5Y) | 2.01 | – |
| Employees | 1,665 | 614 |
| StockData Score | ||
| Total score | 8 | 10 (better) |
| Valuation score | 2 | 3 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 27.9× |
| P/S | 0.0× (better) | 5.6× |
| P/B | 0.0× (better) | 4.6× |
| EV/EBITDA | 0.8× (better) | 25.5× |
| P/FCF | – | 62.4× |
| FCF yield | −140% | 1.6% (better) |
| Fair value | – | $38.16 |
| Margin of safety | – | 10.9% |
| Growth | ||
| Revenue growth (TTM) | −13.6% | 52.0% (better) |
| Revenue growth, 5Y average | −1.0% | – |
| Net income growth (TTM) | −54.4% | 45.7% (better) |
| EPS growth (TTM) | −955% | 43.5% (better) |
| Profitability | ||
| Gross margin | 44.7% | 98.3% (better) |
| Operating margin | 10.6% | 18.8% (better) |
| Net margin | 4.9% | 18.4% (better) |
| FCF margin | −3.7% | 9.0% (better) |
| Return on equity | 4.6% | 38.6% (better) |
| Return on invested capital | 6.2% | 141% (better) |
| Financial health | ||
| Debt / equity | 0.23 | – |
| Net debt / EBITDA | 0.55 | – |
| Interest coverage | 3.2× | – |
| Current ratio | 8.68 (better) | 1.52 |
| Altman Z-score | 0.85 | 6.49 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Payout ratio | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 56.9% | 27.7% |
| Held by insiders | 11.7% | 74.7% |
| Insider net buying, 12 months | $188K (better) | −$89.6M |
| Short interest, % of float | 2.8% | 22.8% |
Go deeper
- EHTH stock overview
- EHTH income statement
- EHTH valuation and score
- LIFE stock overview
- LIFE income statement
- LIFE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.